Cytokines and growth factors modify the upregulation of contractile endothelin ETA and ETB receptors in rat cerebral arteries after organ culture

Acta Physiologica

Volumn 205, Issue 2, 2012, Pages 266-278

  Ahnstedt, H ^a   Stenman, E ^a   Cao, L ^a   Henriksson, M ^a   Edvinsson, L ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Basic fibroblast growth factor; Endothelin receptors; Epidermal growth factor; Interleukin 1 ; Platelet derived growth factor; Tumour necrosis factor

Indexed keywords

CYTOKINE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; INTERLEUKIN 1BETA; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR; SARAFOTOXIN S6C; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; CULTURE MEDIUM; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE CEREBRAL ARTERY; NONHUMAN; ORGAN CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; CEREBRAL ARTERIES; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; INTERLEUKIN-1BETA; MALE; MUSCLE CONTRACTION; ORGAN CULTURE TECHNIQUES; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, WISTAR; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84860249292     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2011.02392.x     Document Type: Article

References (54)

1. Adner, M., Cantera, L., Ehlert, F., Nilsson, L. & Edvinsson, L. 1996. Plasticity of contractile endothelin-B receptors in human arteries after organ culture. Br J Pharmacol 119, 1159-1166.
2. Ansar, S. & Edvinsson, L. 2008. Subtype activation and interaction of protein kinase C and mitogen-activated protein kinase controlling receptor expression in cerebral arteries and microvessels after subarachnoid hemorrhage. Stroke 39, 185-190.
3. Ansar, S. & Edvinsson, L. 2009. Equal contribution of increased intracranial pressure and subarachnoid blood to cerebral blood flow reduction and receptor upregulation after subarachnoid hemorrhage. Laboratory investigation. J Neurosurg 111, 978-987.
4. Armstead, W.M. & Kreipke, C.W. 2011. Endothelin-1 is upregulated after traumatic brain injury: a cross-species, cross-model analysis. Neurol Res 33, 133-136.
5. Barone, F.C., Globus, M.Y., Price, W.J., White, R.F., Storer, B.L., Feuerstein, G.Z., Busto, R. & Ohlstein, E.H. 1994. Endothelin levels increase in rat focal and global ischemia. J Cereb Blood Flow Metab 14, 337-342.
6. Barone, F.C., White, R.F., Elliott, J.D., Feuerstein, G.Z. & Ohlstein, E.H. 1995. The endothelin receptor antagonist SB 217242 reduces cerebral focal ischemic brain injury. J Cardiovasc Pharmacol 26(Suppl 3), S404-S407.
7. Bhardwaj, A., Wu, Y., Hurn, P.D., Kirsch, J.R. & Traystman, R.J. 2000. Administration of selective endothelin receptor type A antagonist Ro 61-1790 does not improve outcome in focal cerebral ischemia in cat. J Cereb Blood Flow Metab 20, 499-504.
8. Buttini, M., Appel, K., Sauter, A., Gebicke-Haerter, P.J. & Boddeke, H.W. 1996. Expression of tumor necrosis factor alpha after focal cerebral ischaemia in the rat. Neuroscience 71, 1-16.
9. Chuquet, J., Benchenane, K., Toutain, J., MacKenzie, E.T., Roussel, S. & Touzani, O. 2002. Selective blockade of endothelin-B receptors exacerbates ischemic brain damage in the rat. Stroke 33, 3019-3025.
10. Crowley, R.W., Medel, R., Dumont, A.S., Ilodigwe, D., Kassell, N.F., Mayer, S.A., Ruefenacht, D., Schmiedek, P., Weidauer, S., Pasqualin, A. & Macdonald, R.L. 2011. Angiographic vasospasm is strongly correlated with cerebral infarction after subarachnoid hemorrhage. Stroke 42, 919-923.
11. Dai, X. & Galligan, J.J. 2006. Differential trafficking and desensitization of human ET(A) and ET(B) receptors expressed in HEK 293 cells. Exp Biol Med (Maywood) 231, 746-751.
12. Dirnagl, U., Iadecola, C. & Moskowitz, M.A. 1999. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22, 391-397.
13. Duan, S.R., Wang, H.H., Qi, J.P., Teng, W.L., Xu, R., Wang, D.S. & Wang, H.T. 2008. [Influences of bFGF and EGF on the proliferation and differentiation of endogenous neural stem cells after cerebral infarction in human]. Zhonghua Yi Xue Za Zhi 88, 3337-3341.
14. Edvinsson, L.I. & Povlsen, G.K. 2011. Vascular plasticity in cerebrovascular disorders. J Cereb Blood Flow Metab 31, 1554-1571.
15. Etminan, N., Vergouwen, M.D., Ilodigwe, D. & Macdonald, R.L. 2011. Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Cereb Blood Flow Metab 31, 1443-1451.
16. Evans, N.J. & Walker, J.W. 2008a. Endothelin receptor dimers evaluated by FRET, ligand binding, and calcium mobilization. Biophys J 95, 483-492.
17. Evans, N.J. & Walker, J.W. 2008b. Sustained Ca2 + signaling and delayed internalization associated with endothelin receptor heterodimers linked through a PDZ finger. Can J Physiol Pharmacol 86, 526-535.
18. Gregan, B., Jurgensen, J., Papsdorf, G., Furkert, J., Schaefer, M., Beyermann, M., Rosenthal, W. & Oksche, A. 2004. Ligand-dependent differences in the internalization of endothelin A and endothelin B receptor heterodimers. J Biol Chem 279, 27679-27687.
19. Hansen-Schwartz, J., Hoel, N.L., Zhou, M., Xu, C.B., Svendgaard, N.A. & Edvinsson, L. 2003. Subarachnoid hemorrhage enhances endothelin receptor expression and function in rat cerebral arteries. Neurosurgery 52, 1188-1194; 1194-5.
20. Henriksson, M., Stenman, E. & Edvinsson, L. 2003. Intracellular pathways involved in upregulation of vascular endothelin type B receptors in cerebral arteries of the rat. Stroke 34, 1479-1483.
21. Henriksson, M., Xu, C.B. & Edvinsson, L. 2004. Importance of ERK1/2 in upregulation of endothelin type B receptors in cerebral arteries. Br J Pharmacol 142, 1155-1161.
22. Hogestatt, E.D., Andersson, K.E. & Edvinsson, L. 1983. Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels. Acta Physiol Scand 117, 49-61.
23. Kallakuri, S., Kreipke, C.W., Schafer, P.C., Schafer, S.M. & Rafols, J.A. 2010. Brain cellular localization of endothelin receptors A and B in a rodent model of diffuse traumatic brain injury. Neuroscience 168, 820-830.
24. Kreipke, C.W., Rafols, J.A., Reynolds, C.A., Schafer, S., Marinica, A., Bedford, C., Fronczak, M., Kuhn, D. & Armstead, W.M. 2011. Clazosentan, a novel endothelin A antagonist, improves cerebral blood flow and behavior after traumatic brain injury. Neurol Res 33, 208-213.
25. Lampl, Y., Fleminger, G., Gilad, R., Galron, R., Sarova-Pinhas, I. & Sokolovsky, M. 1997. Endothelin in cerebrospinal fluid and plasma of patients in the early stage of ischemic stroke. Stroke 28, 1951-1955.
26. Larsen, C.C., Povlsen, G.K., Rasmussen, M.N. & Edvinsson, L. 2011. Improvement in neurological outcome and abolition of cerebrovascular endothelin B and 5-hydroxytryptamine 1B receptor upregulation through mitogen-activated protein kinase kinase 1/2 inhibition after subarachnoid hemorrhage in rats. J Neurosurg 114, 1143-1153.
27. Leseth, K.H., Adner, M., Berg, H.K., White, L.R., Aasly, J. & Edvinsson, L. 1999. Cytokines increase endothelin ETB receptor contractile activity in rat cerebral artery. Neuroreport 10, 2355-2359.
28. Lodge, N.J., Zhang, R., Halaka, N.N. & Moreland, S. 1995. Functional role of endothelin ETA and ETB receptors in venous and arterial smooth muscle. Eur J Pharmacol 287, 279-285.
29. Macdonald, R.L., Kassell, N.F., Mayer, S., Ruefenacht, D., Schmiedek, P., Weidauer, S., Frey, A., Roux, S. & Pasqualin, A. 2008. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke 39, 3015-3021.
30. Macdonald, R.L., Higashida, R.T., Keller, E., Mayer, S.A., Molyneux, A., Raabe, A., Vajkoczy, P., Wanke, I., Bach, D., Frey, A., Marr, A., Roux, S. & Kassell, N. 2011. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol 10, 618-625.
31. Maddahi, A. & Edvinsson, L. 2008. Enhanced expressions of microvascular smooth muscle receptors after focal cerebral ischemia occur via the MAPK MEK/ERK pathway. BMC Neurosci 9, 85.
32. Maddahi, A. & Edvinsson, L. 2010. Cerebral ischemia induces microvascular pro-inflammatory cytokine expression via the MEK/ERK pathway. J Neuroinflammation 7, 14.
33. Maddahi, A., Ansar, S., Chen, Q. & Edvinsson, L. 2011. Blockade of the MEK/ERK pathway with a raf inhibitor prevents activation of pro-inflammatory mediators in cerebral arteries and reduction in cerebral blood flow after subarachnoid hemorrhage in a rat model. J Cereb Blood Flow Metab 31, 144-154.
34. Minami, M., Kuraishi, Y., Yabuuchi, K., Yamazaki, A. & Satoh, M. 1992. Induction of interleukin-1 beta mRNA in rat brain after transient forebrain ischemia. J Neurochem 58, 390-392.
35. Mulvany, M.J. & Halpern, W. 1977. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 41, 19-26.
36. Patel, T.R., Galbraith, S., Graham, D.I., Hallak, H., Doherty, A.M. & McCulloch, J. 1996. Endothelin receptor antagonist increases cerebral perfusion and reduces ischaemic damage in feline focal cerebral ischaemia. J Cereb Blood Flow Metab 16, 950-958.
37. Plate, K.H. 1999. Mechanisms of angiogenesis in the brain. J Neuropathol Exp Neurol 58, 313-320.
38. Renner, O., Tsimpas, A., Kostin, S., Valable, S., Petit, E., Schaper, W. & Marti, H.H. 2003. Time- and cell type-specific induction of platelet-derived growth factor receptor-beta during cerebral ischemia. Brain Res Mol Brain Res 113, 44-51.
39. Sabri, M., Ai, J. & Macdonald, R.L. 2011. Dissociation of vasospasm and secondary effects of experimental subarachnoid hemorrhage by clazosentan. Stroke 42, 1454-1460.
40. Sauvageau, S., Thorin, E., Caron, A. & Dupuis, J. 2006. Evaluation of endothelin-1-induced pulmonary vasoconstriction following myocardial infarction. Exp Biol Med (Maywood) 231, 840-846.
41. Sauvageau, S., Thorin, E., Villeneuve, L. & Dupuis, J. 2009. Change in pharmacological effect of endothelin receptor antagonists in rats with pulmonary hypertension: role of ETB-receptor expression levels. Pulm Pharmacol Ther 22, 311-317.
42. Stenman, E., Malmsjo, M., Uddman, E., Gido, G., Wieloch, T. & Edvinsson, L. 2002. Cerebral ischemia upregulates vascular endothelin ET(B) receptors in rat. Stroke 33, 2311-2316.
43. Stenman, E., Jamali, R., Henriksson, M., Maddahi, A. & Edvinsson, L. 2007. Cooperative effect of angiotensin AT(1) and endothelin ET(A) receptor antagonism limits the brain damage after ischemic stroke in rat. Eur J Pharmacol 570, 142-148.
44. Tatlisumak, T., Carano, R.A., Takano, K., Opgenorth, T.J., Sotak, C.H. & Fisher, M. 1998. A novel endothelin antagonist, A-127722, attenuates ischemic lesion size in rats with temporary middle cerebral artery occlusion: a diffusion and perfusion MRI study. Stroke 29, 850-857; discussion 857-8.
45. Thampatty, B.P., Sherwood, P.R., Gallek, M.J., Crago, E.A., Ren, D., Hricik, A.J., Kuo, C.W., Klamerus, M.M., Alexander, S.A., Bender, C.M., Hoffman, L.A., Horowitz, M.B., Kassam, A.B. & Poloyac, S.M. 2011. Role of endothelin-1 in human aneurysmal subarachnoid hemorrhage: associations with vasospasm and delayed cerebral ischemia. Neurocrit Care 15, 19-27.
46. Thorin, E. & Clozel, M. 2010. The cardiovascular physiology and pharmacology of endothelin-1. Adv Pharmacol 60, 1-26.
47. Uddman, E., Moller, S., Adner, M. & Edvinsson, L. 1999. Cytokines induce increased endothelin ET(B) receptor-mediated contraction. Eur J Pharmacol 376, 223-232.
48. Umemura, K., Ishiye, M., Kosuge, K. & Nakashima, M. 1995. Effect of combination of a tissue-type plasminogen activator and an endothelin receptor antagonist, FR139317, in the rat cerebral infarction model. Eur J Pharmacol 275, 17-21.
49. Vatter, H., Konczalla, J., Weidauer, S., Preibisch, C., Raabe, A., Zimmermann, M. & Seifert, V. 2007a. Characterization of the endothelin-B receptor expression and vasomotor function during experimental cerebral vasospasm. Neurosurgery 60, 1100-1108; discussion 1108-9.
50. Vatter, H., Konczalla, J., Weidauer, S., Preibisch, C., Zimmermann, M., Raabe, A. & Seifert, V. 2007b. Effect of delayed cerebral vasospasm on cerebrovascular endothelin A receptor expression and function. J Neurosurg 107, 121-127.
51. Wang, J.Y., Wilcoxen, K.M., Nomoto, K. & Wu, S. 2007. Recent advances of MEK inhibitors and their clinical progress. Curr Top Med Chem 7, 1364-1378.
52. Watts, S.W. 2010. Endothelin receptors: what's new and what do we need to know? Am J Physiol Regul Integr Comp Physiol 298, R254-R260.
53. White, L.R., Juul, R., Skaanes, K.O. & Aasly, J. 2000. Cytokine enhancement of endothelin ET(B) receptor-mediated contraction in human temporal artery. Eur J Pharmacol 406, 117-122.
54. Xu, C.B., Stenman, E. & Edvinsson, L. 2002. Reduction of bFGF-induced smooth muscle cell proliferation and endothelin receptor mRNA expression by mevastatin and atorvastatin. Biochem Pharmacol 64, 497-505.